Understanding Tissue Responses To Fluid Resuscitation And Blood Transfusion During Ovine Sepsis To Improve Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$980,810.00
Summary
Annually, sepsis affects up to 30 million patients, killing more patients than the combined totals of breast, prostate and lung cancer. Fluid resuscitation is a cornerstone of sepsis therapy, aimed at improving oxygen delivery to key organs. Data now indicates that blood and non-blood fluids may worsen mortality. This study will investigate the mechanism of sepsis and the effect of blood and non-blood fluids, to provide data to clinicians which may reduce the vast global burden of this disease.
STandaRd Issue TrANsfusion VersuS Fresher Red Blood Cell Use In IntenSive CarE (TRANSFUSE) – A Randomised Controlled Trial.
Funder
National Health and Medical Research Council
Funding Amount
$2,890,335.00
Summary
In Australia, blood for transfusions has a “use by” date of 42 days after collection. The actual age of blood given to patients depends on what is available at the time and the rate of usage. Some research has been done to suggest it might help patients in the intensive care unit reach a better recovery if they receive blood transfusions that are younger than this. This project will test whether patients who receive ‘fresher’ blood do better than patients who receive ‘standard issue ’ blood.
Improved Patient Outcomes By Early Intervention With Therapeutic Cooling For Patients With Severe Traumatic Brain Injury, And By Optimising Patient Blood Transfusion Practice In Critically Ill Patients.
Funder
National Health and Medical Research Council
Funding Amount
$380,450.00
Summary
First, a large multicentre trial (POLAR) will complement my previous successful trials in traumatic brain injury (TBI) patients and will establish whether active therapeutic cooling, commenced early after brain injury and continued in intensive care units, will achieve its promise of improving patient outcomes. Second, a national multicentre trial (TRANSFUSE) will establish whether transfusing blood units with a shorter than usual storage time will improve patient outcomes.
Improving Outcomes For Critically Ill Patients After Traumatic Brain Injury And Blood Transfusion
Funder
National Health and Medical Research Council
Funding Amount
$418,049.00
Summary
The Fellowship will support an academic clinician to lead the Alfred Intensive Care Department, and the Monash ANZIC Research Centre. Two pivotal NHMRC supported clinical trials, led by the Fellow, are each the largest and most definitive trials in their fields, and will complete during Fellowship and provide extensive data for research outputs. Concurrently, a new research program to improve patients function and quality of life after critical illness, will be supported.
Centre Of Research Excellence For Patient Blood Management In Critical Illness And Trauma
Funder
National Health and Medical Research Council
Funding Amount
$2,498,410.00
Summary
Blood transfusion is area of major public interest. In critically ill or major trauma patients it can both be life-saving and dangerous. There is continuing uncertainty about how best to use blood and blood products in such patients. The Centre of Research Excellence for Patient Blood Management in Critical Illness and Trauma will undertake vital research to improve our understanding of the effects of transfusion on patient outcomes and how to best manage this vital community resource.